Eric W. Smith

发表

State regulations update: Self‐critical analysis by employees: Trusted privilege or recipe for liability?

William C. Martucci, Eric W. Smith, 1997 .

Interface Extensions for TCP-ENO and tcpcrypt

Mark Handley, Dan Boneh, David Mazières, 2018 .

Interface Extensions for TCP-ENO

Mark Handley, Dan Boneh, David Mazières, 2016 .

The Absolute Fundamentals of Transdermal Permeation (Drug Delivery for Dummies)

Eric W. Smith, Christian Surber, 2000 .

TCP-ENO: Encryption Negotiation Option

Mark Handley, David Mazières, Andrea Bittau, 2019, RFC.

A robust machine code proof framework for highly secure applications

William D. Young, David S. Hardin, Eric W. Smith, 2006, ACL2 '06.

Beyond handbooks: The continud erosion of at‐will status, and one state's legislative efforts to regain control

William C. Martucci, Eric W. Smith, 1997 .

The complete guide to backyard recreation projects

Eric W. Smith, 2010 .

Cryptographic Protection of TCP Streams (tcpcrypt)

Mark Handley, David Mazières, Andrea Bittau, 2019, RFC.

TOPICAL DERMATOLOGICAL VEHICLES : A HOLISTIC APPROACH

Eric W. Smith, H. Maibach, C. Surber, 1999 .

Evaluation of the Proposed FDA Pilot Dose-Response Methodology for Topical Corticosteroid Bioequivalence Testing

Isadore Kanfer, Roderick B. Walker, Eric W. Smith, 2004, Pharmaceutical Research.

Evaluation of the Barrier Function of Skin Using Transepidermal Water Loss (TEWL): A Critical Overview

Howard I. Maibach, Eric W. Smith, H. Maibach, 2014 .

Effect of Concentration and Degree of Saturation of Topical Fluocinonide Formulations on In Vitro Membrane Transport and In Vivo Availability on Human Skin

Eric W. Smith, C. Surber, G. Imanidis, 1999, Pharmaceutical Research.

Assessment of Vehicle Effects by Skin Stripping

Eric W. Smith, C. Surber, Carryn H. Purdon, 2005 .

Solid lipid nanoparticles for topical drug delivery

Eric W. Smith, Carryn H. Purdon, Jin Zhang, 2006 .

Galenical principles in skin protection.

Eric W. Smith, C. Surber, Jin Zhang, 2007, Current problems in dermatology.

The role of percutaneous penetration enhancers

Eric W. Smith, R. B. Walker, 1996 .

Chapter 16 . 4 I ' Assessing Penetration Enhancers for Topical Corticosteroids

Eric W. Smith, J. Haigh, 2007 .

Penetration Enhancement by Skin Hydration

Eric W. Smith, H. Maibach, C. Surber, 2005 .

New developments in the methodology available for the assessment of topical corticosteroid-induced skin blanching

Eric W. Smith, H. Maibach, J. Haigh, 1998 .

The human skin blanching assay for in vivo topical corticosteroid assessment: I. Reproducibility of the assay

Eric W. Smith, I. Kanfer, J. Haigh, 1997 .

Between Blanching Assay and Laboratory Cell Experiments

Eric W. Smith, J. Haigh, 1996 .

Assessing Penetration Enhancers for Topical Corticosteroids

Eric W. Smith, J. Haigh, 1995 .

The Human Skin Blanching Assay for Topical Corticosteroid Bioavailability Assessment

Eric W. Smith, J. Haigh, E. Meyer, 1993 .

Accuracy and Reproducibility of the Multiple-Reading Skin Blanching Assay

Eric W. Smith, J. Haigh, E. Meyer, 1992 .

Penetration enhancement of transdermal delivery--current permutations and limitations.

Eric W. Smith, H. Maibach, Carryn H. Purdon, 2004, Critical reviews in therapeutic drug carrier systems.

Tape-stripping technique

Eric W. Smith, C. Surber, F. Schwarb, 2001 .

The selection and use of natural and synthetic membranes for in vitro diffusion experiments

Eric W. Smith, J. Haigh, 1994 .

Methods for the Assessment of Topical Corticosteroid-Induced Skin Blanching

Eric W. Smith, H. Maibach, J. Haigh, 2002 .

In Vitro Diffusion Cell Design and Validation. I. A Stability-Indicating High-Performance Liquid Chromatographic Assay for Betamethasone 17-Valerate in Purified Isopropyl Myristate Receptor Phase

Eric W. Smith, J. Haigh, 1989, Pharmaceutical Research.

A stability-indicating HPLC assay with on-line clean-up for betamethasone 17-valerate in topical dosage forms

Eric W. Smith, I. Kanfer, J. Haigh, 1985 .

Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.

Eric W. Smith, Jin Zhang, 2011, Journal of pharmaceutical sciences.

The Mystical Effects of Dermatological Vehicles

Eric W. Smith, C. Surber, 2005, Dermatology.

Use of Emulsions as Topical Drug Delivery Systems

Eric W. Smith, H. Maibach, C. Surber, 2000 .

The Vehicle: The Pharmaceutical Carrier of Dermatological Agents

Eric W. Smith, C. Surber, 2000 .

Foam Drug Delivery in Dermatology

Eric W. Smith, C. Surber, J. Haigh, 2003 .

Foam Drug Delivery in Dermatology Beyond the Scalp

Eric W. Smith, C. Surber, J. Haigh, 2003 .

The human skin blanching assay for comparing topical corticosteroid availability

Eric W. Smith, H. Maibach, J. Haigh, 1991 .

Permeation and reservoir formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P) across porcine esophageal tissue in the presence of ethanol and menthol.

Eric W Smith, Eric W. Smith, Daniela Nitcheva, 2006, Carcinogenesis.

ZJ The Human Skin Blanching Assay as an Indicator of TopicalCorticosteroid Bioavailability and Potency : An Update

Eric W. Smith, J. Haigh, E. Meyer, 2007 .

Ointments, Creams and Lotions Used as Topical Drug Delivery Vehicles

Eric W. Smith, C. Surber, Tatiana Tassopoulos, 2002 .